Newsroom

Dr. Lina Herhaus heads the junior research group “Immune Signalling” at the HZI.
News
Scientist Dr. Lina Herhaus, who heads the junior research group “Immune Signaling” at the Helmholtz Centre for Infection Research (HZI), will receive one of the coveted Exploration Grants from the Boehringer Ingelheim Stiftung starting in March 2026. This program offers outstanding basic researchers in biology, chemistry and medicine the opportunity to explore new directions in research. In addition, Herhaus received the Walther Flemming Award from the German Society of Cell Biology (DGZ) and ibidi GmbH on October 27, 2025. The prize is endowed with 3,000 euros and is awarded to experienced postdoctoral researchers and young scientists for outstanding achievements in cell biology.
29.10.2025
Portrait Caroline Klett-Tammen
Interview
Poliomyelitis, also known as polio, is a contagious disease caused by the poliovirus. Thanks to the development of effective vaccines, the poliovirus has been largely eradicated and was endemic in only two countries in 2024. However, until the virus is eradicated worldwide, vaccination protection is important in Germany as well, as the virus could be reintroduced at any time. Epidemiologists at the Helmholtz Centre for Infection Research (HZI) have now shown that many people do not know their vaccination status and cannot find it on their vaccination record. In an interview on the occasion of World Polio Day on October 24, Dr. Carolina Klett-Tammen, deputy head of Clinical Epidemiology in the department “Epidemiology” at the HZI, explains the study results, which have been published in the journal BMC Public Health.
23.10.2025
Light microscopy of red blood cells, some are infected with Plasmodium
News
It has long been known that bacterial pathogens are becoming increasingly resistant to antibiotics. However, common medications are also becoming less effective against malaria, a tropical disease caused by a parasite. To counteract this development, a research team at the Helmholtz Institute for Pharmaceutical Research Saarland (HIPS), in collaboration with the Swiss Tropical and Public Health Institute (Swiss TPH), has now developed a new drug candidate that can kill the malaria pathogen even when existing drugs are no longer effective. The team has now published its findings in the journal Angewandte Chemie.
22.10.2025
Fluorescence microscopy of cells in magenta and blue
News
Natural products derived from microorganisms are a promising source of new active ingredients, but are often produced only in very small quantities. A research team from the Helmholtz Institute for Pharmaceutical Research Saarland (HIPS) led by Tobias Gulder has now succeeded in establishing a chemo-enzymatic platform for the production of furanolides – a class of natural products with a broad spectrum of activity. This strategy not only allows furanolides to be produced cost-effectively, but also enables structural modifications to be made. The newly generated molecules are capable of effectively combating both bacterial pathogens and cancer cells. The team has now published its findings in the Journal of the American Chemical Society.
20.10.2025
Two speakers in front of a presentation on a screen
News
On 9 and 10 October 2025, the One Lab Retreat of the Helmholtz Centre for Infection Research (HZI) took place at the Wyndham Hannover Atrium. Researchers, managers and task force representatives from all HZI sites came together to present current scientific results, discuss interdisciplinary topics and further develop strategic cooperation.
13.10.2025
Rolf Müller
News
Professor Rolf Müller, Scientific Director of the Helmholtz Institute for Pharmaceutical Research Saarland (HIPS) and Professor of Pharmaceutical Biology at Saarland University, has been awarded the Mannich Medal by the German Pharmaceutical Society (DPhG). Awarded in honour of the German chemist Carl Mannich, the medal is the DPhG's highest scientific accolade and is presented annually for “outstanding achievements in the field of pharmaceutical sciences”. The medal was presented at the DPhG's annual conference in Freiburg on October 1, 2025. HIPS is a site of the Helmholtz Centre for Infection Research (HZI) in collaboration with Saarland University.
07.10.2025

HZI in the media

Dr. Rolf Müller, Managing Director of Helmholtz Institute for Pharmaceutical Research Saarland (HIPS), were both named laureates of the

22.12.2025
|
Research Information

... ein Interview mit Josef Penninger geführt . Er ist wissenschaftlicher Geschäftsführer des Helmholtz-Zentrum für Infektionsforschung in ...

21.12.2025
|
T3N

Institut für RNA-basierte Infektionsforschung (HIRI), einem Standort des Braunschweiger Helmholtz-Zentrums für Infektionsforschung (HZI) in ...

19.12.2025
|
healthcare-in-europe.com

Biosyntheseweg aufzuklären. Das HIPS ist ein Standort des Helmholtz-Zentrums für Infektionsforschung (HZI) in Zusammenarbeit mit ...

18.12.2025
|
Bionity.COM

Finanzierungsmöglichkeiten fehlen.

 

Josef Penninger, wissenschaftlicher Geschäftsführer des Helmholtz-Zentrums für Infektionsforschung (HZI)

16.12.2025
|
MedMedia

Korte from the Technical University of Braunschweig and the Helmholtz Centre for Infection Research (HZI).

 

The research was carried out as

12.12.2025
|
The Hindu

... des Leibniz Lungenzentrums Borstel, des Helmholtz-Instituts für Pharmazeutische Forschung Saarland sowie weiterer wissenschaftlicher ...

12.12.2025
|
Bionity.COM

Einrichtungen des regionalen Forschungsökosystems – darunter das Helmholtz-Zentrum für Infektionsforschung (HZI), das Deutsche Zentrum für

12.12.2025
|
EUROPE SAYS

Korte of the Technical University of Braunschweig and the Helmholtz Centre for Infection Research (HZI). The findings emerged from the

12.12.2025
|
The New Indian Express

Universität Würzburg. Seit 2018: Postdoc am Helmholtz-Institut für RNA-basierte Infektionsforschung (HIRI), Entwicklung Bayes’scher ...

12.12.2025
|
BIOspektrum

Center Borstel - Leibniz Lung Center, the Helmholtz Institute for Pharmaceutical Research Saarland and other scientific institutions in

11.12.2025
|
Technology Networks

von Humboldt professor, head of department at the Helmholtz Centre for Infection Research, Braunschweig and full professor at the Hannover

10.12.2025
|
European Research Council

Register now for the HZI-Newsletter